The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway

Abstract

Our data indicated that KRAS promoted ovarian cancer dissemination by stabilizing spheroid formation and that the MEK pathway is important for stabilized spheroid formation. Disruption of spheroid formation by a MEK inhibitor could be a therapeutic target for cancer peritoneal dissemination.